Clinical Trial Update: Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the utility of 18F-FDOPA PET/MRI for focal hyperinsulinism and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperinsulinism

Snippet

Sponsor: Washington University School of Medicine | Conditions: Hyperinsulinism | Phase 2 | Status: RECRUITING